Reduction of HLA-DR+ Lymphocytes after Treatment with Enzastaurin in Patients with Metastatic Thyroid Cancer

Publisher： Karger

E-ISSN： 1421-9794|54|4|268-273

ISSN： 0009-3157

Source： Chemotherapy, Vol.54, Iss.4, 2008-07, pp. : 268-273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Place of Targeted Agents in the Treatment of Elderly Patients with Metastatic Colorectal Cancer

By Matikas Alexios   Asimakopoulou Natalia   Georgoulias Vassilis   Souglakos John  

Cancers, Vol. 7, Iss. 1, 2015-03 ,pp. : 439-449

MDPI

Access to resources Recommend Favorite

Induction of a Regulatory Phenotype in CD3+ CD4+ HLA-DR+ T Cells after Allogeneic Mixed Lymphocyte Culture; Indications of Both Contact-Dependent and -Independent Activation

By Revenfeld Anne Louise Schacht   Bæk Rikke   Jørgensen Malene Møller   Varming Kim   Stensballe Allan  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-07 ,pp. : 1603-1603

MDPI

Access to resources Recommend Favorite

Concerns about Breast Cancer, Pain, and Fatigue in Non-Metastatic Breast Cancer Patients Undergoing Primary Treatment

By Amiel Chelsea R.   Fisher Hannah M.   Antoni Michael H.  

Healthcare, Vol. 4, Iss. 3, 2016-08 ,pp. : 62-62

MDPI

Access to resources Recommend Favorite

Interstitial Pneumonitis after Treatment with Bevacizumab and Pegylated Liposomal Doxorubicin in a Patient with Metastatic Breast Cancer

By  

Chemotherapy, Vol. 56, Iss. 1, 2010-02 ,pp. : 69-70

Karger

Access to resources Recommend Favorite

Irinotecan-Cetuximab-Bevacizumab as a Salvage Treatment in Heavily Pretreated Metastatic Colorectal Cancer Patients: A Retrospective Observational Study

By  

Chemotherapy, Vol. 57, Iss. 2, 2011-03 ,pp. : 138-144

Karger

Access to resources Recommend Favorite